SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Teva Pharmaceutical Industries Limited Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia in Breast Cancer Patients Undergoing Chemotherapy